At the very outset, this remarkable, robust, rational and recent judgment authored by the Single Judge Bench comprising of Hon’ble Mr Justice M Nirmal Kumar of Madras High Court sets the ball in ...

Growth across the Manufacturing and RMS segments is likely to have contributed to Charles River's fourth-quarter revenues.

Read here for an analysis of Charles River's (CRL) strong financial performance with high ROE and decreasing liabilities, ...

Payday lenders took in $2.4 billion in fees from cash-strapped consumers in a single year, a report from the Center for ...

In a report released on February 1, Casey Woodring from J.P. Morgan maintained a Hold rating on Charles River Labs (CRL – Research Report), ...

Supernus Pharmaceuticals has won US approval for its wearable pump Onapgo (apomorphine hydrochloride) to treat symptoms of ...

Morgan Stanley analyst Tejas Savant lowered the firm’s price target on Charles River (CRL) to $184 from $220 and keeps an Equal Weight rating ...

Supernus Pharmaceuticals' FDA approval for ONAPGO in Parkinson's Disease offers optimism despite past challenges, with a ...

It is definitely a matter of utmost significance to note that the Delhi High Court in a most learned, laudable, landmark, ...

Banks were hoping that President Donald Trump’s election alongside a Republican Congress would make their lives easier.

A teacher in South Africa allegedly cut off a religious thread from the wrist of a Hindu student, triggering condemnation ...

Shares of Charles River Laboratories International Inc. CRL shed 1.91% to $161.62 Monday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index SPX ...